Ignite Creation Date:
2024-10-25 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06551701
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-05
Brief Title:
ACHIEVE Pilot Statins for Vascular Protection
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Cluster-randomized Trial to Improve Use of High IntEnsity Statins for Vascular Protection
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ACHIEVE
Brief Summary:
ACHIEVE aims to increase statin usage among patients with ASCVD by having a pharmacist talk to patients and providers
Detailed Description:
Atherosclerotic cardiovascular disease ASCVD is the leading cause of death in the United States US Statins reduce the risk of cardiovascular events by 30 in those with prior history of ASCVD Despite being inexpensive and well-tolerated however statins are underused in clinical practice particularly in patients who identify as Black A large-scale intervention to improve evidence-based statin initiation among individuals with ASCVD is needed particularly for the Black population To meet this need we aim to conduct a multi-center pragmatic cluster randomized controlled trial to assess the impact of a provider- and patient-directed intervention to increase the prescription of and adherence to appropriate statin therapy among those with ASCVD ACHIEVE A Controlled trial to improve use of High IntEnsity statins for Vascular protEction The intervention will be pharmacist-led embedded in commercial payer systems partnering with the National Committee for Quality Assurance NCQA and with a particular emphasis on improving statin use in the Black population
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None